Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 49-50
© 2002 European Renal Association-European Dialysis and Transplant Association

SECTION IV: Dialysis fluid purity

IV.4 Haemodialysishyphen;proportioning machine

Abstract

The haemodialysis machine is the proportioning system that mixes the electrolyte concentrate solution (or powder) with the purified water to produce the dialysis fluid with characteristics (electrolytic composition, pH, temperature, dialysis fluid flow) complying with the medical prescription set on the dialysis monitor. The final composition of the dialysis fluid relies on the dialysis-proportioning machine itself that is warranted by the manufacturer and its conditions of use. This specific point of view will not be discussed here. However, from the safety point of view, it is important to remind that any user is responsible for the safe use of a well functioning dialysis machine to treat a patient. This basic safety precaution is valid in any circumstances and applies to every dialysis session.

Guideline IV.4.1

A. The safe accomplishment of any dialysis session requires that the dialysis fluid composition is correct and that any disinfectant is completely removed before the start.

(Evidence level: C)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
G. A. Knoll, I. MacDonald, A. Khan, and C. van Walraven
Mycophenolate Mofetil Dose Reduction and the Risk of Acute Rejection after Renal Transplantation
J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2381 - 2386.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.